Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has informed that a meeting of the Board of Directors of the Company will be held on November 07, 2015, to consider and take on record the Unaudited Financial Results of the Company for the second quarter and six months ended September 30, 2015 (Q2). Further, window closure for trading by designated persons as per Insider Trading Rules of the Company will be from October 29, 2015 to November 10, 2015.

The above information is a part of company’s filings submitted to BSE.